Sunho Biologics, Inc. (02898)

AuditorFromToRelease Date / Document LinksReason for Change
KTC Partners CPA29-Jun-26
KTC Partners CPA05-Jun-26
Deloitte Hong Kong16-May-24
Zhonghui Anda CPA16-Sept-2505-Jun-26SUPPLEMENTAL ANNOUNCEMENT: During the 2025 annual audit, the auditor encountered scope limitations and outstanding audit issues relating to verification of the commercial substance and counterparties of certain service agreements and upfront payments. The auditor stated additional time was required, could not provide a clear timetable to complete the audit due to outstanding third‑party information, and expressed intention to resign if items remained unresolved. It formally tendered a resignation letter with immediate effect on 2026-06-05, creating a casual vacancy later ratified at an EGM on 2026-06-29.
Deloitte15-Sept-25In view of the more competitive proposal provided by other professional accounting firms, the Board and the Audit Committee consider that the change of Auditor would enhance the cost-effectiveness of the audit of the Company.
Deloitte09-Sept-25Could not reach a consensus on the audit fee.